Abstract: There is provided cephalosporin derivatives of the formula ##STR1## in which R.sup.1 is carboxy-lower alkyl andR.sup.2 is hydrogen, a cation or (with the oxygen atom) a readily hydrolyzable ether group,as well as readily hydrolyzable esters and salts of these compounds and hydrates of the compounds of formula I and of their esters and salts. Also provided are methods for their manufacture and pharmaceutical preparations containing the compounds of formula I.

Abstract: There is presented compounds of the formula ##STR1## wherein X represents the 1,2,5,6-tetrahydro-2-methyl- 5,6-dioxo-as-triazin-3-yl group or its corresponding tautomeric form, the 2,5-dihydro-6-hydroxy-2-methyl-5-oxo-as-triazin-3-yl group, and the readily hydrolyzable esters, readily hydrolyzable ethers and salts of the compounds and hydrates of the compounds of formula I or of their esters, ethers and salts. Also provided is a method of their manufacture and intermediates therefor as well as corresponding pharmaceutical preparations.

Abstract: There are presented cephalosporin derivatives of the formula ##STR1## wherein X is the group ##STR2## R is hydrogen or a readily hydrolyzable ester or ether group and n stands for 1 or 2, as well as salts of these compounds and hydrates of these compounds and salts.

Abstract: There are presented cephalosporin derivatives of the formula ##STR1## wherein X is the group ##STR2## R is hydrogen or a readily hydrolyzable ester or ether group and n stands for 1 or 2,as well as salts of these compounds and hydrates of these compounds and salts.

Abstract: Cephalosporins represented by the formulaX--S--Ywherein X is a deacetoxycephalosporinyl group and Y is a 6-membered heterocyclic group containing 1-3 nitrogens at least one of which is substituted and at least one of which is adjacent to a carbonyl group, said heterocyclic group containing one or more ring substituents and being characterized by being non-aromatic and non enolizable to an aromatic form.

Abstract: Acyl derivatives of the formula ##STR1## wherein R signifies hydrogen or a protective group which can be split off, R.sup.1 signifies lower alkyl and X signifies the group ##STR2## wherein one of the residues R.sup.2 and R.sup.3 represents hydrogen and the other represents alkyl and R.sup.4 represents lower alkylthe easily hydrolyzable esters and ethers thereof, the salts and hydrates of the above compounds, esters, ethers and salts.

Abstract: An implantable drug depot for the treatment of diseases of the bone or bone marrow. The depot consisting of a matrix in which at least one active ingredient is incorporated and contains at least one adjuvant agent to control the kinetics of the drug release. The matrix material consists of resorbable sintered calcium phosphate composed of CaO and P.sub.2 O.sub.5 in a ratio between 5:1 and 2:1.

Abstract: For surface modification of natural or synthetic macromolecular substrates, organic compounds are used that have hydrophilic, hydrophobic, oleophobic, ionic and/or cross-linkable groups and that also have groups which are easily convertible to nitrene or carbene, e.g., azide or diazo groups. Such organic compounds are applied to the surface to be modified as a monolayer or oligolayer from a solution thereof and then are photochemically activated. Conditions which cause orientation of the molecule with the azide or diazo group toward the surface of the substrate are advantageous. The other cross-linkable groups may promote diagonal cross-linking of the applied layer.

Abstract: There is presented cephalosporin derivatives which are the readily hydrolysable esters and ethers of compounds of the general formula ##STR1## wherein R represents furyl, thienyl or phenyl optionally substituted by halogen, hydroxy, lower alkoxy or lower alkyl, R.sub.1 represents lower alkyl or aminocarbonylmethyl and X represents a group of the formula ##STR2## in which one of the two symbols R.sub.2 and R.sub.3 represents hydrogen and the other represents lower alkyl and R.sub.4 represents lower alkyl,as well as salts of said esters and ethers and hydrates of said esters, ethers and salts.

Abstract: A process for the production of a composite membrane consisting of a porous supporting membrane and a thin separating membrane. The separating membrane is produced on the surface of a carrier film (consisting essentially of a soluble polymer). The carrier film coated with the separating membrane is placed with its separating membrane side on a porous supporting membrane such that the separating membrane is between the supporting membrane and the carrier film. The carrier film is then dissolved.

Abstract: An implantable prosthesis anchorage which contains a non-porous outer coating in the regions which is positioned in contact with bone. The non-porous outer coating consists of (i) at least one bioactive resorbable ceramic material which is a calcium phosphate and (ii) at least one polymer which is mechanically and chemically stable in the body. The ceramic material is in particulate form having particle diameters between 0.5 and 1 mm. The ceramic material particles is incorporated in the polymer in such a way that resorption of the ceramic material leads to a polymer structure with continuous pores filled with living bone tissue. Bioactivating bonding residues of the ceramic material are left on the inner surfaces of the filled pores which were created by the resorption of the ceramic material.

Abstract: Bone replacement or prosthesis anchoring material on the basis of sintered calcium phosphates which consists of a mixture of calcium phosphates with low or high-molecular-weight organic substances. More specifically, the anchoring material consists of a mixture of calcium phosphates composed of CaO and P.sub.2 O.sub.5 in a quantitative ratio of 2:1 to 4:1 with biodegradable polymers in a ratio of 10:1 to 1:1 of phosphate to polymer and is implantable as a solid body. A method for the production of the material wherein calcium phosphate with a porosity of 15 to 30 volume percent is used and its pores are filled by impregnation with polymer material.

Abstract: An artificial tooth with an implantable root adapted to permanently grow together with the jawbone and, also under high mechanical loads as is the case for natural teeth, will not allow for the production of a rejection or repelling reaction between the natural bone and the implant. The tooth root is essentially constituted of a biostable polymer matrix which is compatible with human tissue, in which there is introduced reabsorbable bioreactive calcium phospate in a finely dispersed form, which is encompassed by a thin porous layer of non-reabsorbable calcium phospate, and into which there is inserted a core as a connecting member for the mounting of a dental superstructure in the form of a tooth crown, a fastening element for dental bridges or the like.

Abstract: The acyl derivatives provided by the present invention are compounds of the general formula ##STR1## wherein R represents furyl, thienyl or phenyl optionally substituted by halogen, hydroxy, lower alkoxy or lower alkyl, R.sub.1 represents alkyl or aminocarbonylmethyl and X represents a group of the formula ##STR2## in which one of the two symbols R.sub.2 and R.sub.3 or R.sub.4 and R.sub.5 represents hydrogenand the other represents lower alkyl, carboxymethyl or sulphomethyl, and the pharmaceutically acceptable salts of said compounds and hydrates of said salts.Also disclosed are a process for the manufacture of the compounds and pharmaceutical preparations therefor.The compounds of the present invention have antibiotic activity, especially bactericidal activity.

Abstract: Cephalosporins represented by the formulaX-S-Ywherein X is a deacetoxycephalosporinyl group and Y is a 6-membered heterocyclic group containing 1-3 nitrogens at least one of which is substituted and at least one of which is adjacent to a carbonyl group, said heterocyclic group containing one or more ring substituents and being characterized by being non-aromatic and not enolizable to an aromatic form.

Abstract: Compounds represented by the following formula ##STR1## wherein R is hydrogen, lower alkanoyloxymethyl, lower alkyl, indanyl or a radical represented by the formula ##STR2## wherein X may be hydrogen, halogen, hydroxy, lower alkyl, lower alkoxy or a lower alkoxy-lower alkyl group,Pharmaceutically acceptable salts and hydrates thereof. These compounds are useful as antibiotics.